The patients in the ITGB1 high-expression group were significantly older and had higher CA19-9 levels (p = 0.037 and 0.039, respectively), but other clinicopathological factors such as preoperative tumor marker levels and lymph node metastasis were not significantly different (Table 1). This evidence concerns the gene ITGB1 and neoplasm.